NYSE:STE - Steris Stock Price, Forecast & News

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, STE shares have decreased by 5.2% and is now trading at $137.70. View which stocks have been mosted impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Steris.

Steris is scheduled to release its next quarterly earnings announcement on Monday, May 11th 2020. View our earnings forecast for Steris.

Steris PLC (NYSE:STE) announced its quarterly earnings results on Monday, February, 10th. The medical equipment provider reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.42 by $0.03. The medical equipment provider earned $774.30 million during the quarter, compared to analysts' expectations of $748.45 million. Steris had a net margin of 13.21% and a return on equity of 16.33%. The business's quarterly revenue was up 11.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.26 earnings per share. View Steris' earnings history.

Steris declared a quarterly dividend on Monday, February 10th. Shareholders of record on Tuesday, February 25th will be paid a dividend of $0.37 per share on Thursday, March 26th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date is Monday, February 24th. View Steris' dividend history.

Steris issued an update on its FY 2020 After-Hours earnings guidance on Monday, February, 10th. The company provided earnings per share guidance of 5.65-5.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.57.

4 Wall Street analysts have issued twelve-month price targets for Steris' stock. Their forecasts range from $138.00 to $150.00. On average, they anticipate Steris' share price to reach $144.33 in the next year. This suggests a possible upside of 4.8% from the stock's current price. View analysts' price targets for Steris.

News headlines about STE stock have been trending very negative this week, according to InfoTrie Sentiment. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Steris earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutSteris.

Steris saw a decline in short interest in the month of March. As of March 13th, there was short interest totaling 1,275,100 shares, a decline of 18.8% from the February 27th total of 1,570,000 shares. Based on an average trading volume of 881,000 shares, the days-to-cover ratio is currently 1.4 days. Approximately 1.5% of the shares of the stock are short sold. View Steris' Current Options Chain.

Some companies that are related to Steris include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Insulet (PODD), Masimo (MASI) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Mastercard (MA), AbbVie (ABBV), Mcdonald's (MCD), Gilead Sciences (GILD), Allergan (AGN), Pfizer (PFE), Stryker (SYK), AT&T (T) and Zimmer Biomet (ZBH).

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of STE stock can currently be purchased for approximately $137.70.

Steris has a market capitalization of $11.68 billion and generates $2.78 billion in revenue each year. The medical equipment provider earns $304.05 million in net income (profit) each year or $4.89 on an earnings per share basis. Steris employs 12,000 workers across the globe. View additional information about Steris.

The official website for Steris is http://www.steris.com/.

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]